𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure

✍ Scribed by Wang, Yiming; Pratt, Julian R; Hartley, Barrie; Evans, Beryl; Zhang, Lyna; Sacks, Steven H

Book ID
109884894
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
946 KB
Volume
52
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of urokinase-type plasminogen
Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease
✍ Slobodan Miseljic; Susan Galandiuk; Stephen D. Myers; Dr. James L. Wittliff πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 488 KB πŸ‘ 1 views

Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR I
TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA
✍ WAGNER, STEPHAN N.; ATKINSON, MICHAEL J.; THANNER, STEPHANIE; SCHMITT, MANFRED; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 597 KB

In experimental models, plasminogen activator-mediated degradation of the extracellular matrix is inhibited by type-1 plasminogen activator inhibitor (PAI-1). PA14 has also been shown to protect tumour stromal tissue from autoproteolytic activities and may thus substantially promote tumour growth an